STS 2017 心房颤动外科治疗临床实践指南
该指南由胸外科医师学会制定,针对心房颤动外科消融的适应证与时机给出推荐。核心推荐包括:二尖瓣手术同期行外科消融恢复窦性心律(I类,A级);孤立主动脉瓣置换、孤立冠状动脉旁路移植或两者联合时同期消融(I类,B级非随机);无结构性心脏病、药物或导管治疗难治的症状性房颤可考虑独立消融(IIA类,B级随机);左房扩大或中重度以上二尖瓣反流时独立肺静脉隔离不推荐(III类无获益,C级专家意见)。
要点
- 二尖瓣手术同期行外科消融恢复窦性心律为I类推荐(A级证据)。
- 孤立主动脉瓣置换或冠脉旁路移植同期消融为I类推荐(B级非随机)。
- 左房≥4.5 cm或中重度以上二尖瓣反流时独立肺静脉隔离不推荐。
核心结论
- 外科消融治疗房颤可在不增加手术死亡或主要并发症风险的前提下进行,并在多种心脏手术同期推荐用于恢复窦性心律。
研究设计与样本
- 该指南由胸外科医师学会(STS)制定,基于证据等级与推荐类别对房颤外科治疗给出临床实践推荐。
主要发现
- 二尖瓣手术同期消融推荐级别为I类、A级;孤立主动脉瓣置换、孤立冠脉旁路移植及两者联合同期消融为I类、B级非随机。
- 无结构性心脏病、I/III类抗心律失常药或导管治疗难治的症状性房颤,独立消融为IIA类、B级随机。
- 无结构性心脏病的症状性持续或长程持续房颤,独立Cox-Maze III/IV较单独肺静脉隔离为IIA类、B级非随机。
- 左房扩大(≥4.5 cm)或中重度以上二尖瓣反流时,单独肺静脉隔离不推荐(III类无获益,C级专家意见)。
关键数值与推荐
- 二尖瓣手术同期消融:I类,A级。
- 孤立主动脉瓣置换、孤立冠脉旁路移植或联合手术同期消融:I类,B级非随机。
- 无结构性心脏病难治性症状性房颤独立消融:IIA类,B级随机。
- 左房≥4.5 cm或中重度以上二尖瓣反流时独立肺静脉隔离:III类无获益,C级专家意见。
- 房颤外科消融同期左心耳切除或隔离:IIA类,C级有限数据;心脏手术同期处理左心耳:IIA类,C级专家意见。
临床怎么用
- 在二尖瓣手术、孤立主动脉瓣置换或冠脉旁路移植同期,应积极考虑外科消融以恢复窦性心律。
- 对药物或导管难治的无结构性心脏病症状性房颤,可评估独立外科消融。
- 左房显著扩大或中重度以上二尖瓣反流时,避免单独肺静脉隔离。
- 房颤外科消融同期建议处理左心耳以预防长期血栓栓塞。
- 推荐多学科心脏团队评估、治疗规划及长期随访以优化预后。
局限性
- 部分推荐基于专家意见(C级)或有限数据,证据等级较低。
- 部分推荐基于非随机研究(B级非随机),可能存在偏倚。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Surgical ablation for atrial fibrillation (AF) can be performed without additional risk of operative mortality or major morbidity, and is recommended at the time of concomitant mitral operations to restore sinus rhythm. (Class I, Level A) Surgical ablation for AF can be performed without additional operative risk of mortality or major morbidity, and is recommended at the time of concomitant isolated aortic valve replacement, isolated coronary artery bypass graft surgery, and aortic valve replacement plus coronary artery bypass graft operations to restore sinus rhythm. (Class I, Level B nonrandomized) Surgical ablation for symptomatic AF in the absence of structural heart disease that is refractory to class I/III antiarrhythmic drugs or catheter-based therapy or both is reasonable as a primary stand-alone procedure, to restore sinus rhythm. (Class IIA, Level B randomized) Surgical ablation for symptomatic persistent or longstanding persistent AF in the absence of structural heart disease is reasonable, as a stand-alone procedure using the Cox-Maze III/IV lesion set compared with pulmonary vein isolation alone. (Class IIA, Level B nonrandomized) Surgical ablation for symptomatic AF in the setting of left atrial enlargement (≥4.5 cm) or more than moderate mitral regurgitation by pulmonary vein isolation alone is not recommended. (Class III no benefit, Level C expert opinion) It is reasonable to perform left atrial appendage excision or exclusion in conjunction with surgical ablation for AF for longitudinal thromboembolic morbidity prevention. (Class IIA, Level C limited data) At the time of concomitant cardiac operations in patients with AF, it is reasonable to surgically manage the left atrial appendage for longitudinal thromboembolic morbidity prevention. (Class IIA, Level C expert opinion) In the treatment of AF, multidisciplinary heart team assessment, treatment planning, and long-term follow-up can be useful and beneficial to optimize patient outcomes. (Class I, Level C expert opinion).
引用
- Badhwar V, Rankin JS, Damiano RJ, et al. The Society of Thoracic Surgeons 2017 Clinical Practice Guidelines for the Surgical Treatment of Atrial Fibrillation. Ann Thorac Surg. 2017. PMID: 28007240. doi:10.1016/j.athoracsur.2016.10.076
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。